Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Despite accelerating progress towards schistosomiasis control in sub-Saharan Africa, several age groups have been eclipsed by current treatment and monitoring strategies that mainly focus on school-aged children. As schistosomiasis poses a threat to people of all ages, unfortunate gaps exist in current treatment coverage and associated monitoring efforts, preventing subsequent health benefits to preschool-aged children as well as certain adolescents and adults. Expanding access to younger ages through the forthcoming pediatric praziquantel formulation and improving treatment coverage in older ages is essential. This should occur alongside formal inclusion of these groups in large-scale monitoring and evaluation activities. Current omission of these age groups from treatment and monitoring exacerbates health inequities and has long-term consequences for sustainable schistosomiasis control. Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.


Christina L Faust, Derick N M Osakunor, Jennifer A Downs, Sekeleghe Kayuni, J Russell Stothard, Poppy H L Lamberton, Jutta Reinhard-Rupp, David Rollinson. Schistosomiasis Control: Leave No Age Group Behind. Trends in parasitology. 2020 Jul;36(7):582-591

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 32430274

View Full Text